Market Tracker

04/25 4:29am ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.17
Delayed Data
As of Apr 24
 +0.05 / +1.60%
Today’s Change
2.83
Today|||52-Week Range
7.74
-22.30%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close3.12
Today’s open3.17
Day’s range3.14 - 3.22
Volume1,102,270
Average volume (3 months)3,106,002
Market cap$407.4M
Dividend yield--
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.05+0.76%
ASMBAssembly Biosciences...-0.17-0.71%
ARNAArena Pharmaceutical...+0.06+4.62%
MYOKMyoKardia Inc+0.30+2.37%
Data as of 04/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts